Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMelphalanBone MarrowAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyBone and BonesStem CellsDisease-Free SurvivalCyclophosphamideLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationBone Marrow PurgingEtoposideRecurrenceHodgkin DiseaseGraft vs Host DiseaseCarmustineHematopoietic Stem CellsCytarabineMyeloablative AgonistsLiver TransplantationSurvival RateWhole-Body IrradiationGraft SurvivalSurvival AnalysisHematologic NeoplasmsVincristineAntigens, CD34Retrospective StudiesBusulfanThiotepaPrognosisGranulocyte Colony-Stimulating FactorDoxorubicinFollow-Up StudiesKidney TransplantationDexamethasoneTime FactorsLymphoma, Mantle-CellLeukapheresisAmyloidosisCell TransplantationAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedThalidomideTransplantation ChimeraBoronic AcidsPyrazinesMesenchymal Stem Cell TransplantationLymphomaAntineoplastic AgentsTissue DonorsLymphoma, FollicularPrednisoneLymphoma, T-Cell, PeripheralBone RemodelingNeoplasm, ResidualLeukemia, Myeloid, AcuteAutograftsHematopoiesisIfosfamideMyelodysplastic SyndromesCord Blood Stem Cell TransplantationCell DifferentiationHeart TransplantationImmunosuppressive AgentsInduction ChemotherapyPodophyllotoxinLeukemiaLung TransplantationIdarubicinCells, CulturedLymphoma, Large B-Cell, DiffuseBlood Component RemovalAntibodies, MonoclonalProspective StudiesHistocompatibility TestingMaintenance ChemotherapyBone DensityFeasibility StudiesBone Marrow DiseasesTransplantation ImmunologyGraft RejectionLymphoma, B-CellFlow CytometryLeukemia, MyeloidHistocompatibilityT-LymphocytesOrgan Transplantation